Goldman Sachs’s iKang Healthcare Group, Inc. KANG Stock Holding History

Goldman Sachs’s Portfolio KANG Stock Details KANG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-22,000	Closed	-$297K	–	6864
2017 Q3	$297K	Buy	+22,000	New	+$294K	﹤0.01%	5475
2016 Q4	–	Sell	-200	Closed	-$4K	–	7214
2016 Q3	$4K	Sell	200 -1,000	-83%	-$18.4K	﹤0.01%	6939
2016 Q2	$22K	Sell	1,200 -1,000	-45%	-$20.1K	﹤0.01%	6701
2016 Q1	$48K	Sell	2,200 -3,900	-64%	-$81.2K	﹤0.01%	6455
2015 Q4	$125K	Buy	6,100 +100	+2%	+$1.73K	﹤0.01%	6048
2015 Q3	$89K	Buy	+6,000	New	+$97.2K	﹤0.01%	6550

Goldman Sachs's KANG Position: Q1 2019 in Review

Goldman Sachs sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 4,372,992 shares — an estimated $89.1M sold.

Goldman Sachs first reported a position in KANG in Q3 2014 and held it in 18 quarters. The position peaked at $191M in Q1 2015. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.

Goldman Sachs reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
Goldman Sachs sold 4,372,992 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $89.1M.
Goldman Sachs first reported a position in iKang Healthcare Group, Inc. in Q3 2014 and held it in 18 quarters.
Goldman Sachs's iKang Healthcare Group, Inc. position peaked at $191M in Q1 2015.
0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.

Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.